Invitrogen™ Human CCDC22 Synthetic Peptide

Ref.: BL-RE-175471Manufacturer ref.: PEP-1449 50 μg
€149.00 excl. VAT

CCDC22 Synthetic Peptide, PEP-1449, from Invitrogen.

Gene ID (Enter)
28952
Species
Human
Purification method
Purified
Accession number
O60826
Common name
Human CCDC22
Brand
Invitrogen

CCDC22 Synthetic Peptide, PEP-1449, from Invitrogen.

CCDC22 Synthetic Peptide, PEP-1449, from Invitrogen.

CCDC22 is a recently identified coiled-coil domain-containing protein that has been shown to bind copines, which are calcium-dependent, membrane-binding proteins that may function in calcium signaling. In rat, CCDC22 has been observed to localize in multiple regions of the brain, including the prefrontal and somatosensory cortex, dentate gyrus and thalamus, and in the ipsilateral motor neurons of the spinal cord after sciatic nerve transection suggesting that it may play a role in neuronal injury response. The human CCDC22 gene has been identified as a novel candidate gene for syndromic X-linked intellectual disability (XLID).

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15245359
Specifications
Gene ID (Enter)28952
SpeciesHuman
Purification methodPurified
Accession numberO60826
Common nameHuman CCDC22
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)CCDC22
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1449
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.